ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT07090330 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07090330
- Sponsor
- Oruka Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2026-03-25
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.